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Abstract
Background: Miyoshi myopathy (MM) is an autosomal recessive distal myopathy characterized by early adult onset. 
Cardiomyopathy is a major clinical manifestation in other muscular dystrophies and an important prognostic factor. 
Although dysferlin is highly expressed in cardiac muscle, the effect of dysferlin deficiency in cardiac muscle has not 
been studied. We hypothesized that early myocardial dysfunction could be detected by 2D strain echocardiography 
and late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR).
Method: Five consecutive MM patients (3 male) in whom we detected the DYSF gene mutation and age-matched 
healthy control subjects were included. None of the patients had history of cardiac disease or signs and symptoms of 
overt heart failure. Patients were studied using 2D strain echocardiography and CMR, with 2D strain being obtained 
using the Automated Function Imaging technique.
Results: All patients had preserved left ventricular systolic function. However, segmental Peak Systolic Longitudinal 
Strain (PSLS) was decreased in 3 patients. Global PSLS was significantly lower in patients with MM than in control 
subjects (p = 0.005). Basal anterior septum, basal inferior septum, mid anterior, and mid inferior septum PSLS were 
significantly lower in patients with MM than in control subjects (P < 0.0001, < 0.0001, 0.038 and 0.003, respectively). 
Four patients showed fibrosis by LGE. The reduced PSLS lesion detected by 2D strain tended to be in the same area as 
that which showed fibrosis by LGE.
Conclusions: Patients with MM showed subclinical involvement of the heart. 2D strain and LGE are sensitive methods 
for detecting myocardial dysfunction prior to the development of cardiovascular symptoms. The prognostic 
significance of these findings warrants further longitudinal follow-up.
Background
Miyoshi Myopathy (MM) is a distinct form of muscular
dystrophy caused by mutations within the dysferlin
(DYSF) gene resulting in severe to complete deficiency of
dysferlin expression[1,2]. Clinically, these dysferlinopa-
thies start in young adulthood with progressive muscle
weakness and atrophy that advances to severe disability in
older adulthood. While the profound effect of dysferlin
deficiency in skeletal muscle has been the subject of
much investigation, the effect of dysferlin deficiency in
cardiac muscle have not been studied yet. Kuru et al[3]
reported a 57-year-old Japanese woman with dysferlinop-
athy manifested as secondary dilated cardiomyopathy
attributable to muscular dystrophy. Recently, Wenzel et
al[4] described that 2 of 7 patients with dysferlinopathy
who had progressive shortness of breath had dilated car-
diomyopathy. Five other dysferlinopathy patients who
had no cardiac symptoms had other cardiac abnormali-
ties such as left ventricular hypertrophy and repolariza-
tion abnormalities. These observations suggest that
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dysferlin deficiency can lead to cardiomyopathy as well as
to muscular dystrophy. Therefore, this study aimed to
detect early cardiac involvement in patients with asymp-
tomatic MM by using 2D strain by echocardiography
(echo) and late gadolinium enhancement (LGE) by car-
diovascular magnetic resonance (CMR).
Methods
Study population
Five consecutive index patients (three male and two
female) in whom a DYSF gene mutation and distal myo-
pathy was documented gave written informed consent.
Five healthy subjects (mean age 43.8 ± 12.7 years) were
enrolled as age-matched controls. The institutional
review board of the Samsung Medical Center approved
this study. The recommendations of the revised version
of the Declaration of Helsinki were met. Cardiac involve-
ment was investigated with conventional methods using
standard 12-channel surface-electrocardiography (ECG),
transthoracic echocardiography, and CMR.
Transthoracic echocardiography
Transthoracic echocardiograms were performed with a
commercially available echocardiographic instrument
(Vivid 7, GE Medical Systems, Milwaukee, WI). A stan-
dard comprehensive M-mode, 2-D echocardiogram and
echocardiographic Doppler studies were performed.
Examinations included measurements of left ventricular
(LV) volume and ejection fraction (EF), using the biplane
disc method, and the left atrial volume index. All mea-
surements were made according to the recommendations
of the American Society of Echocardiography. Mitral
inflow was obtained by pulsed-wave Doppler echocar-
diography, with the sample volume between mitral leaflet
tips during diastole, and mitral annulus velocities were
obtained from the septal and lateral annulus by tissue
Doppler imaging. All measurements were performed
over three cardiac cycles and then averaged.
Strain measurement using the automated function 
imaging technique (AFI)
Global LV longitudinal strain was assessed using the
automated function imaging (AFI) technique, which pro-
vides a new imaging modality based on 2-dimensional
longitudinal strain imaging[5-7]. Longitudinal strain
(percentage) is defined as the physiologic change in
length of the region of interest from end-diastole to end-
systole. During this period, strain in the longitudinal
direction is a negative value as the length of the region of
interest decreases. Longitudinal strain can be calculated
using the following formula: longitudinal strain (%) = [L
(end-systole) - L (end-diastole)]/L (end-diastole) × 100%;
where L is the length of the region of interest. Assessment
o f  g l o b a l  L V  l o n g i t u d i n a l  s t r a i n  ( A F I  g l o b a l  L V  s t r a i n ;
described by the software as GLPS_Avg) provides 1 value
representing the overall peak systolic longitudinal strain
of all individual LV segments. With the commercially
available AFI technique (General Electrics, Milwaukee,
Wisconsin, USA), myocardial tissue deformation (strain)
is calculated using speckle tracking from 2-dimensional
grey scale images. For this analysis, a set of three longitu-
dinal 2-dimensional image planes (apical long-axis, 2-
and 4-chamber views) was used. Aortic valve closure tim-
ing was marked (to determine the end of systole) in the
selected views and three points were anchored inside the
myocardial tissue, two placed at the basal segments along
the mitral valve annulus and one at the apex. These
points triggered the automatic process, which analyzed
myocardial motion by tracking features (natural acoustic
tags). The percent of wall lengthening and shortening was
displayed for each plane, representing longitudinal strain.
The results of all three planes were then combined in a
single bull's-eye summary, which presents the analysis for
each segment along with a global strain value for the LV.
For global LV longitudinal strain analysis, digital cine-
loops were off-line processed using commercially avail-
able software (EchoPac 6.1, GE Medical Systems, Horten,
Norway). All images were obtained at a frame rate of 50-
80 frames/sec without dual focus. Three consecutive car-
diac cycles were saved in digital format for off-line analy-
sis. Investigators who were blinded to clinical features or
CMR findings performed the strain analysis.
Cardiovascular magnetic resonance (CMR)
All patients were scanned using a 1.5-T scanner (Achieva
1.5 T; Philips Medical Systems, Best, The Netherlands).
Criteria for exclusion from the study included generally
accepted contraindication to CMR, but no patient had to
be excluded. CMR focused on the detection of fibrosis
(LGE). Volumetric evaluation of LV mass, volume, and EF
by manual tracing were performed. Various pulse
sequences were used for imaging. ECG-gated double
inversion-recovery images (TE = 10 ms), triple inversion-
recovery images (TE = 100 msec), transverse or short-
axial breath-hold cine MR images (balanced turbo field
echo [TFE], TR/TE = 3.1/1.6 ms) were usually obtained
before contrast injection. After injection of contrast
material (gadobutrol at 0.1-0.15 mmol/kg at a rate of 3
mL/s, Gadovist; Bayer Schering Pharma, Berlin, Ger-
many), post injection images were obtained using late
myocardial imaging (T1 fast field echo, TR/TE = 4.5/1.4
ms) with suppression of the normal myocardial signals 5,
10, and 15 minutes later. A Look-Locker sequence was
applied to determine optimal inversion time for myocar-
dial nulling before delayed myocardial imaging in every
instance.Choi et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:31
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Statistical analysis
Data are reported as mean ± standard deviation. We used
unpaired 2-sided t test to assess differences between
groups (patients with MM vs controls) for normally dis-
tributed continous data. Parametric Man-Whitey test
were used if data were nor normally distributed. All anal-
yses were performed using commercially available soft-
ware (SPSS version 10.0, SPSS Inc., Chicago, IL, and JMP,
SAS Institute Inc., Cary, NC) and a p value < 0.05 was
considered significant.
Results
Patient characteristics
The history, laboratory, and clinical data of the patients
are shown in Table 1. None of the patients had a cardiac
history or signs and symptoms of overt heart failure such
as dyspnea on exertion or peripheral edema. All the
patients experienced early adulthood onset of slowly pro-
gressive muscle weakness that preferentially involved
muscles in the lower extremities. Creatine kinase (CK)
levels were characteristically elevated in all patients.
ECG findings
All patients were in sinus rhythm. Left ventricular hyper-
trophy (LVH) was present in two patients (patients #2
and #4). In patient #2, left anterior fascicular block was
also detected.
Standard echocardiographic measurements
The data from standard echocardiography are summa-
rized in Table 2. All subjects had preserved ejection frac-
tion. Patient #4 showed mildly decreased left ventricular
systolic function (LVEF = 45%) and hypokinesia of the
basal and mid inferior wall. Echocardiographic findings
of the other patients were unremarkable.
2D strain by AFI
Table 2 shows the PSLS measured by AFI. Although all
five patients had preserved left ventricular systolic func-
tion, segmental PSLS was significantly decreased in
patients #1, #2, and #4. In patient #1, the segmental PSLS
was decreased in the basal to mid inferolateral wall. In
patient #2, the segmental PSLS was decreased in the basal
to mid anterolateral wall. In patient #3, the segmental
PSLS was near normal. In patient #4, the segmental PSLS
was decreased in inferior and basal anteroseptal wall. In
patient #5, segmental PSLS was normal (Figure 1(A)).
Comparison between patients with MM and age-matched 
healthy control subjects
There were no difference between patients with MM and
age-matched healthy controls regarding age, sex, blood
pressure, and heart rate. Echocardiographic parameters,
including LVEDD, LVESD, LVEF, E, A, E/A ratio, E', and
E/E' ratio were not significantly different between MM
patients and control subjects. For 2D strain parameters,
Table 1: History, clinical and laboratory finding of patients
#1 #2 #3 #4 #5
A g e 3 04 23 56 25 0
sex M M F M F
Other risk factor None DM/HTN None DM/HTN none
Blood pressure (mmHg) 130/74 169/115 128/82 91/64 116/73
H e a r t  r a t e  ( b p m ) 6 99 97 37 06 5
Lab CK(IU/l) 4822 1794 3520 528 2362
NT-pro 
BNP(pg/mL)
29.27 20.93 34.75 156.2 18.62
DYSF mutation c.[1284+2T>C]
+[2997G>T]
c.3307A>T,c.4
201insC
c.2974T>A c.[1284+2T>
C(+)2974T>C]
c.[3112C>T]
+[3112C>T]
Family Hx - - - + -
A g e  o f  o n s e t 1 81 81 83 43 7
U/Ex proximal 4+ 4+ 5 4 5
distal 4+ 3 5 4- 5
L/Ex proximal 5 2 4 4+ 5
distal 4 2424 -
ECG NSR NSR, LVH, 
LAFB
NSR NSR, LVH NSR
U/Ex = upper extremity, L/Ex = lower extremity, ECG = electrocardiography, NSR = normal sinus rhythm, LVH = left ventricular hypertrophy, 
LAFB = left anterior fascicular block.Choi et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:31
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Table 2: Echocardiographic parameters in patients with Miyoshi myopathy
#1 #2 #3 #4 #5
LVEDD (mm) 50 54 47 56 41
LVESD (mm) 30 31 30 44 25
Ejection Fraction 
(%)
64 67 59 45 63
E velocity (m/sec) 0.91 0.89 0.80 0.42 0.64
A velocity (m/sec) 0.54 0.51 0.60 0.61 0.66
E/A ratio (m/sec) 1.69 1.75 1.33 0.69 0.97
E' velocity (m/sec) 0.11 0.10 0.09 0.05 0.073
E/E' ratio 8.27 8.9 8.89 8.40 8.77
RWMA (-) (-) (-) Hypokinesia of 
basal and mid 
inferior wall
(-)
Global PSLS (%) -15.7 -20.9 -17.4 -16.8 -23.4
PSLS at long-axis 
view (%)
-12.8 -19.3 -17.1 -17.0 -24.6
PSLS at 4-
chamber view (%)
-16.8 -20.9 -18.9 -16.0 -22.7
PSLS at 2-
chamber view (%)
-17.4 -22.7 -16.2 -17.3 -22.9
Segmental PSLS
Basal Anterior -22 -15 -24 -15 -22
AS -15 -18 -16 -13 -18
IS -17 -18 -16 -12 -18
Inferior -17 -18 -23 -9 -25
IL 4 -17 -19 -14 -25
AL -18 -11 -20 -12 -26
Mid Anterior -14 -13 -24 -17 -22
AS -18 -19 -17 -22 -25
IS -19 -18 -18 -15 -21
Inferior -19 -19 -21 -12 -24
IL -11 -15 -21 -13 -25
AL -15 -9 -21 -19 -22
Apical anterior -15 -16 -21 -23 -25
septum -20 -21 -23 -25 -28
Inferior -20 -29 -22 -18 -25
lateral -15 -17 -23 -25 -24
Apical cap -17 -18 -22 -23 -26
LVEDD = left ventricular end-diastolic diameter, LVESD = left ventricular end-systolic diameter, E = peak transmitral flow velocity during early 
diastole, A = peak transmitral flow velocity during late diastole, E'= peak mitral annular velocity during early diastole, RWMA = regional wall 
motion abnormality, PSLS = peak systolic longitudinal strain, AS = anteriorseptum, IS = inferiorseptum, IL = inferiorlateral, AL = anteriorlateral.Choi et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:31
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global PSLS was significantly lower in patients with MM
than in control subjects (p = 0.005). Basal anterior sep-
tum PSLS, basal inferior septum PSLS, mid anterior
PSLS, and mid inferior septum PSLS were significantly
lower in patients with MM than in control subjects (P <
0.0001, < 0.0001, 0.038 and 0.003, respectively) (Table 3).
LGE by CMR
The median inversion times for delayed myocardial imag-
ing were 220 ms, 270 ms, and 310 ms for 5-minute, 10-
minute, and 15-minute delayed scan, respectively. The
detailed measurement data are shown in Table 4. The
results of LGE by CMR were abnormal in four patients.
Patient #1 showed mid anterior and anterolateral seg-
ment with myocardial fibrosis. Patient #2 had focal fibro-
sis in the basal to mid anterolateral wall. Patient #3 did
not have evidence of myocardial fibrosis. Patient #4 had
fibrosis in inferior area and mid wall fibrosis in basal
anteroseptal wall (Figure 1(B-D)). Patient #5 had focal
fibrosis in the septal side of the left ventricle. (See addi-
tional file 1 and 2: Movie for LGE in CMR).
Discussion
The main finding of our study is patients with MM
showed subclinical involvement of the heart. Echo with
2D strain and LGE are sensitive methods of assessing the
presence of myocardial dysfunction prior to the develop-
ment of any cardiovascular symptoms. Miyoshi myopa-
Figure 1 Patient #4: (A) Automated function imaging (AFI) segmental PSLS by Echocardiography. Segmental PSLS was decreased in inferior 
and basal anteroseptal area. (B-D) Cardiovascular Magnetic Resonance. (B,C) Late gadolinium enhancement images in the short-axis view (delay 
10 minutes). There was fibrosis in inferior and basal anteroseptal area (arrow). (C) Late gadolinium enhancement images in the four-chamber view 
(delay 20 minutes). There was fibrosis in inferoseptal area (arrow).Choi et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:31
http://www.jcmr-online.com/content/12/1/31
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Table 3: Comparison between in patients with Miyoshi myopathy and age-matched health control subjects
Patients with
MM (n = 5)
Control
(n = 5)
p-value
Age 43.8 ± 12.7 43.8 ± 12.7 1.0
Sex(Female) 2 2 1.0
SBP 126.8 ± 28 124.8 ± 18 0.883
DBP 81.6 ± 19 75.0 ± 10 0.527
HR 75.2 ± 14 69.8 ± 7.8 0.423
LVEDD (mm) 49.6 ± 5.9 49.2 ± 3.3 0.888
LVESD (mm) 32.0 ± 7.1 29.6 ± 3.2 0.518
Ejection Fraction (%) 59.6 ± 8.6 63.5 ± 3.8 0.379
E velocity (m/sec) 0.73 ± 0.20 0.85 ± 0.06 0.239
A velocity (m/sec) 0.58 ± 0.06 0.57 ± 0.05 0.777
E/A ratio (m/sec) 1.29 ± 0.46 1.51 ± 0.21 0.347
E' velocity (m/sec) 0.08 ± 0.02 0.09 ± 0.01 0.529
E/E' ratio 8.64 ± 0.29 9.61 ± 1.56 0.209
Global PSLS (%) -18.8 ± 3.2 -24.4 ± 1.8 0.005
PSLS at long-axis view (%) -18.2 ± 4.3 -24.1 ± 1.9 0.017
PSLS at 4-chamber view (%) -19.1 ± 2.8 -22.9 ± 2.9 0.019
PSLS at 2-chamber view (%) -19.3 ± 3.2 -24.4 ± 2.7 0.010
Segmental PSLS
Basal Anterior -19.6 ± 4.3 -23.4 ± 1.7 0.102
AS -16.0 ± 2.1 -22.5 ± 1.1 <0.0001
IS -16.2 ± 2.5 -23.4 ± 1.2 <0.0001
Inferior -18.4 ± 6.2 -22.3 ± 1.6 0.213
IL -14.2 ± 1.9 -21.9 ± 2.9 0.162
AL -17.4 ± 6.1 -22.6 ± 2.6 0.106
Mid Anterior -18.0 ± 4.8 -23.4 ± 2.3 0.038
AS --20.2 ± 3.3 -22.1 ± 2.2 0.248
IS -18.2 ± 2.2 -22.9 ± 2.2 0.003
Inferior -19.0 ± 4.4 -22.4 ± 2.4 0.137
IL -17.0 ± 5.8 -21.9 ± 1.7 0.109
AL -18.6 ± 5.6 -23.2 ± 2.8 0.164
Apical anterior -20.0 ± 4.4 -22.9 ± 2.7 0.206
septum -23.4 ± 3.2 -23.1 ± 2.8 0.86
Inferior -22.8 ± 4.3 -22.7 ± 2.6 0.947
lateral -20.8 ± 4.5 -21.7 ± 2.2 0.684
Apical cap -21.2 ± 3.7 -22.6 ± 2.5 0.463
SBP = systolic blood pressure, DBP = diastolic blood pressure, HR = heart rate, LVEDD = left ventricular end-diastolic diameter, LVESD = left 
ventricular end-systolic diameter, E = peak transmitral flow velocity during early diastole, A = peak transmitral flow velocity during late 
diastole, E'= peak mitral annular velocity during early diastole, PSLS = peak systolic longitudinal strain, AS = anterior septum, IS = inferior 
septum, IL = inferior lateral, AL = anterior lateral.Choi et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:31
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thy (MM) is an autosomal recessive distal myopathy
characterized by early adult onset. MM is believed to
spare the heart. However, recently, few case of cardiac
involvement in MM reported. In our study, subclinical
cardiac involvement was detected by 2D stain and LGE.
Although most of patients had preserved LVEF, segmen-
tal PSLS was decreased in three patients by 2D strain and
fibrosis was shown in four patients by LGE. In patient #1,
there was discrepancy the abnormality between 2D strain
and LGE. 2D strain was decreased in the basal to mid inf-
erolateral area, but there were fibrosis in mid anterolat-
e r a l  a r e a  i n  L G E .  I n  p a t i e n t  # 2 ,  s e g m e n t a l  P S L S  w a s
decreased in the basal to mid anterolateral wall and there
was focal fibrosis in same area. In patient #3, 2D strain
and LGE were normal. In patient #4, 2D strain was
decreased in inferior and basal anteroseptal area and
there were fibrosis in inferior and mid wall basal
anteroseptal area. Particularly in patient #4, it is reason-
able that the abnormal results in the inferior area could
be related to ischemic heart disease. Cardiac CT angiog-
raphy showed non-significant stenosis (about 40%) in the
right coronary artery. Considering the result of cardiac
CT angiography, abnormality of the anteroseptal area was
not be related to ischemic heart disease. The reduced
PSLS detected by 2D strain tended to be in the same area
as that which showed fibrosis in LGE in patient #2 and #4
among 5 patients. In patient #5, there was only focal sep-
tal fibrosis in LGE with normal 2D strain. It seems like
nonspecific septal fibrosis in patient #5.
Myocardial strain imaging is useful for quantitative
assessment of regional wall motion of the left ventricle. In
our study, myocardial strain profile in MM patients with
apparently normal 2-dimensional echocardiography were
abnormal. Myocardial strain abnormalities are prevalent
MM patients despite normal EF. Therefore, abnormal
strain value would be early indicators of abnormal cardiac
function in MM. Detection of such strain abnormalities
might allow a better identification of MM cardiac dys-
function and might provide useful surrogate index to
assess therapeutic efficacy. MM patients should be care-
fully evaluated for cardiac involvement using by conven-
tional echocardiography, 2D strain and/or CMR. Any
cardiac dysfunction should be promptly treated accord-
ing to current guidelines. If the treatment were effective,
decreased cardiac strain profile might be improved in fol-
low up study. Further studies with long-term follow-up
with a larger patient population are needed to determine
the role of myocardial strain in preclinical diagnosis of
myocardial impairment in MM. In other myopathies,
such as Duchenne muscular dystrophy (DMD), patients
with normal LV function showed myocardial strain pro-
files at the posterolateral wall of the LV that were differ-
ent from those in healthy controls, suggesting abnormal
myocardial contraction [7]. An earlier report demon-
strated that in young patients with DMD who have glob-
ally normal systolic function, reductions in systolic
deformation parameters could be detected in the antero-
lateral and inferolateral wall [8]. 2D strain appears to
d e t e c t  e a r l y  c h a n g e s  i n  m y o c a r d i a l  f u n c t i o n  i n  D M D
patients before the onset of overt cardiomyopathy.
CMR has better sensitivity and could be used to assess
ventricular size and function as well as to evaluate the
characteristics of myocardial tissue. Specifically, LGE is
used to evaluate myocardial fibrosis, which is present in
dystrophinopathy patients. Silva et al [9] demonstrated
LGE in seven of 10 patients with Duchenne and Becker
muscular dystrophy. Recently, Puchalski et al [10] dem-
onstrated that LGE was present in the basal inferolateral
left ventricular free wall in a subepicardial distribution
and extended to the basal inferior and basal anterolateral
Table 4: The results of CMR in patients with Miyoshi myopathy
#1 #2 #3 #4 #5
fibrosis Mid anterior, 
mid 
anterolateral
Basal to mid 
inferolateral
No evidence of 
myocardial 
fibrosis
Basal to mid 
inferior, basal 
anteroseptal
septal side
LVEF (%) 53.7 53.8 53.7 41.4 59.7
Stroke volume 
(ml)
61.9 73.9 44.2 43.5- 44.3
Cardiac output 
(l/min)
4.3 6.4 2.9 3.04- 2.5 l
LVEDV (ml) 115.3 137.3 82.2 156.03 74.16
LVESV (ml) 53.4 64.5 38.1 91.49 29.9
LVEDWM (g) 80.1 169.8 47.9 112.89 49.56
LVEF = left ventricular ejection fraction, LVEDV = left ventricular end-diastolic volume, LVESV = left ventricular end-systolic volume, LVEDWM 
= Left ventricular end-diastolic wall mass.Choi et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:31
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regions. These findings are consistent with necropsy
studies that showed that the posterobasal abnormality
spread to the epicardial third of the contiguous lateral LV
free wall, with progressive transmural fibrous replace-
ment and relative sparing of the right ventricle and ven-
tricular septum [11,12].
The impact of subclinical cardiac involvement in MM
remains to be assessed. Importantly, most MM patients
may remain asymptomatic for years in spite of the pro-
gression of cardiac dysfunction because of their limited
daily activities. Early detection of latent myocardial
involvement before heart failure symptoms appear would
be beneficial for delaying the progression of heart failure
in MM. Therefore, follow-up is required. The findings of
2D strain and LGE are almost identical in MM patients.
Thus, 2D strain and LGE could suggest subclinical early
cardiac involvement and could be a noninvasive diagnos-
tic screening test for evaluation of cardiac involvement in
MM patients. Early recognition of cardiac involvement in
MM is warranted, because adequate and appropriate
therapy influences the further management and disease
course of patients with primary myopathies [13].
There are several limitations to our study. First, our
sample size was small. Although additional studies would
be necessary to establish further the cardiac involvement
in MM, the rarity of the disease may preclude a large-
scale trial. Second, both of patient #2 and #4 had a history
of hypertension and diabetes mellitus (DM). The dura-
tions of DM for patients #2 and #4 were 10 years and 22
years, respectively. It is possible that the cardiac involve-
ment is not associated with the primary myopathy but
rather with other risk factors, such as DM and hyperten-
sion. In patient #4, cardiac CT angiography showed mild
stenosis (about 40%) in the right coronary artery. Consid-
ering the result of cardiac CT angiography, abnormality
of the anteroseptal area was not related to ischemic heart
disease. To exclude coronary artery disease, coronary
angiography should be performed. Third, we did not
obtain cardiac biopsies for definite confirmation of car-
diac involvement in the MM patients.
Conclusion
2D strain echo and LGE CMR were abnormal in Miyoshi
myopathy patients with preserved left ventricular func-
tion and no overt heart failure symptoms. 2D strain and
LGE could constitute a new diagnostic test to detect pre-
clinical cardiac involvement in Miyoshi myopathy
patients before the onset of overt cardiomyopathy.
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Additional file 1 Cardiovascular Magnetic resonance - Late gadolin-
ium enhancement inversion recovery images in the short-axis view.
Additional file 2 Cardiovascular Magnetic resonance - Late gadolin-
ium enhancement inversion recovery images in the short-axis view.
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